Exact Mass: 200.00940280000003
Exact Mass Matches: 200.00940280000003
Found 97 metabolites which its exact mass value is equals to given mass value 200.00940280000003,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
D-Erythrose 4-phosphate
D-Erythrose 4-phosphate is a phosphorylated derivative of erythrose that serves as an important intermediate in the pentose phosphate pathway. It is also used in phenylalanine, tyrosine and tryptophan biosynthesis, and it plays a role in vitamin B6 metabolism (KEGG); Erythrose 4-phosphate is an intermediate in the pentose phosphate pathway and the Calvin cycle. In addition, it serves as a precursor in the biosynthesis of the aromatic amino acids tyrosine, phenylalanine, and tryptophan. D-Erythrose 4-phosphate is found in many foods, some of which are shea tree, bog bilberry, arrowhead, and dock. D-Erythrose 4-phosphate is a phosphorylated derivative of erythrose that serves as an important intermediate in the pentose phosphate pathway. It is also used in phenylalanine, tyrosine and tryptophan biosynthesis, and it plays a role in vitamin B6 metabolism (KEGG). Acquisition and generation of the data is financially supported in part by CREST/JST.
D-Erythrulose 4-phosphate
A ketotetrose phosphate that is D-erythrulose carrying a phosphono substituent at position O-4.
Sevoflurane
Sevoflurane is only found in individuals that have used or taken this drug. Sevoflurane (2,2,2-trifluoro-1-[trifluoromethyl]ethyl fluoromethyl ether), also called fluoromethyl, is a sweet-smelling, non-flammable, highly fluorinated methyl isopropyl ether used for induction and maintenance of general anesthesia. Together with desflurane, it is replacing isoflurane and halothane in modern anesthesiology. [Wikipedia]Sevoflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. Sevoflurane also activates calcium dependent ATPase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. It also appears to bind the D subunit of ATP synthase and NADH dehydogenase and also binds to the GABA receptor, the large conductance Ca2+ activated potassium channel, the glutamate receptor, and the glycine receptor. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general > N01AB - Halogenated hydrocarbons COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
L-erythrulose 4-phosphate
A ketotetrose phosphate that is L-erythrulose carrying a phosphono substituent at position O-4.
4-Vinylphenol sulfate
4-Vinylphenol sulfate, also known as 4-vinylphenol sulphuric acid, is a member of the class of compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. 4-Vinylphenol sulfate is practically insoluble (in water) and an extremely strong acidic compound (based on its pKa). 4-Vinylphenol sulfate can be found in blood and urine.
3,5-Dinitrocatechol
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors
OR-486
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors
1-(4-CHLOROBENZOYL)-3-METHYL-2-(TRIFLUOROMETHYL)-1H-INDOLE
2-(Methylthio)-6,7-dihydrothieno[3,2-d]pyrimidin-4-ol
C7H8N2OS2 (200.00780379999998)
2-Chloroethanethioic acid S-(4-methylphenyl) ester
1-(3-CHLORO-3-PHENYLPROPYL)PYRROLIDINEHYDROCHLORIDE
3-Carboxy-5-chlorophenylboronic acid
C7H6BClO4 (200.00476559999998)
1,3-Dichloro-2-(acetoxymethoxy)propane
C6H10Cl2O3 (200.00069700000003)
5-chloro-3-methylsulfanyl-2,4-diazabicyclo[4.3.0]nona-2,4,10-triene
butanoic acid, 4-chloro-4,4-difluoro-3-oxo, -ethyl ester
(5,5-DIMETHYL-2,4-DIOXOIMIDAZOLIDIN-1-YL)-ACETIC ACID
4-CARBOXY-2-CHLOROPHENYLBORONIC ACID
C7H6BClO4 (200.00476559999998)
4-Chloro-3-(dihydroxyboryl)benzoic acid
C7H6BClO4 (200.00476559999998)
2-(Trimethylsilyl)ethanesulfonyl chloride
C5H13ClO2SSi (200.00940280000003)
TRANS-2-CHLORO-6-FLUOROCINNAMIC ACID 9&
C9H6ClFO2 (200.00403380000003)
1,1,2,2-Tetrafluoroethyl 2,2,2-Trifluoroethyl Ether
2-Chloro-4-(dihydroxyboryl)benzoic acid
C7H6BClO4 (200.00476559999998)
(2E)-3-(4-Chloro-2-fluorophenyl)acrylic acid
C9H6ClFO2 (200.00403380000003)
6,7-DIFLUORO-2,3-DIHYDRO-4H-1-BENZOTHIOPYRAN-4-ONE
2-{[(2S)-2-hydroxypropyl]sulfanyl}ethanesulfonic acid
C5H12O4S2 (200.01769919999998)
5-(5-Chlorothiophen-2-yl)-2-methyl-3,4-dihydropyrazole
1,2,3,4,7,7-Hexafluorobicyclo[2.2.1]hepta-2,5-diene
sevoflurane
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general > N01AB - Halogenated hydrocarbons COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
D-Erythrose 4-phosphate
An erythrose phosphate that is D-erythrose carrying a phosphate group at position 4. It is an intermediate in the pentose phosphate pathway and Calvin cycle.
4-Vinylphenol sulfate
An aryl sulfate that is 4-hydroxystyrene in which the hydroxy group has been replaced by a sulfooxy group.